Academia vs. big pharma: A comparison

被引：0

作者：

Merrill, J. E. ^{[1
]}

机构：

[1] Sanofi Aventis, Bridgewater, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：96 / 96

页数：1

共 50 条

[1] South Africa vs. big pharma
Birmingham, K
[J]. NATURE MEDICINE, 2001, 7 (04) : 390 - 390
[2] South Africa vs. big pharma
Karen Birmingham
[J]. Nature Medicine, 2001, 7 : 390 - 390
[3] Academia and Big Pharma United
Ljunggren, Hans-Gustaf
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (217)
[4] When big pharma courts academia
Paone, J
[J]. SCIENTIST, 2002, 16 (02): : 48 - 49
[5] Biotechs follow big pharma lead back into academia
Kling, Jim
[J]. NATURE BIOTECHNOLOGY, 2011, 29 (07) : 555 - 556
[6] Transforming big pharma into big academia - Yale University West Campus
Incarvito, Christopher
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[7] Biotechs follow big pharma lead back into academia
Jim Kling
[J]. Nature Biotechnology, 2011, 29 : 555 - 556
[8] From academia, to startup, to big pharma, and back again?
Landrum, Gregory
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[9] Industry vs. academia
Torday, JS
[J]. SCIENTIST, 2001, 15 (10): : 6 - 6
[10] Training: Industry vs. academia
Banks, J
[J]. IIE SOLUTIONS, 2000, 32 (11): : 23 - 23